Displaying items by tag: division of cardiovascular disease

A novel detergent-like compound developed by UAB researchers that blocks HIV and HSV viruses from entering cells could have the same effect against the virus that causes COVID-19. The team is exploring the compound’s potential with a commercialization grant from the U.S. Economic Development Administration.

A bioluminescent one-two punch targets mitochondria in cancer cells and evades the blood-brain barrier for a potential new treatment for neuroendocrine cancers, triple-negative breast cancer and brain cancers.

Lab-grown human heart tissue could mean better drug tests, faster transplants and more accurate models of disease. To get there, Palaniappan Sethu, Ph.D., is stretching ingenuity.

In a talk at UAB on March 6, the NIH director shared his thoughts on exceptional opportunities for science and young scientists — and highlighted several exciting UAB projects.

Learn how UAB researchers are taking on the most feared complication of the new generation of blood-thinning drugs. 

Pay-to-publish journals are often outright scams and undermine the foundation of legitimate research, says Arline Savage, Ph.D. Here’s how faculty and their departments can defend themselves.